-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
OBJECTIVE : Disease-specific studies report impaired humoral responses following SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with specific immunosuppressant.
OBJECTIVE : A disease-specific study reported impaired humoral responses following SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with specific immunosuppressant.
Methods : A cohort study was conducted among participants treated in outpatient clinics at seven university hospitals and a rheumatology treatment center in the Netherlands, as well as participants in two national cohort studies on COVID-19- related disease severit.
Methods : A cohort study was conducted among participants treated in outpatient clinics at seven university hospitals and a rheumatology treatment center in the Netherlands , as well as participants in two national cohort studies on COVID-19- related disease severit.
Results Results : Between February 2 and August 1 , 2021 , there were 3222 participants in the cohor.
Conclusions Conclusions : The humoral response after vaccination is impaired by specific immunosuppressan.
Source: Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort stu.
leave a message here